# Imaging in MGUS, SMM and MM

> **NCT01237054** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 31 (actual)

## Conditions studied

- Multiple Myeloma
- Smoldering Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance

## Interventions

- **DRUG:** 18-NaF PET
- **OTHER:** DCE-MRI
- **DRUG:** 18-FDG PET/CT

## Key facts

- **NCT ID:** NCT01237054
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-17
- **Primary completion:** 2011-08-09
- **Final completion:** 2011-08-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01237054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01237054, "Imaging in MGUS, SMM and MM". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT01237054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*